Arrowhead Pharmaceuticals to Participate in Upcoming March 2020 Conferences

On March 2, 2020 Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported that it is scheduled to participate in the following upcoming events (Press release, Arrowhead Pharmaceuticals, MAR 2, 2020, View Source [SID1234555133]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Global Healthcare Conference– Miami, March 10-12, 2020

March 11, 11:15 a.m. ET – Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will participate in a hybrid podium/fireside chat presentation

5th Annual Oligonucleotide & Precision Therapeutics Congress– Cambridge, MA, March 16-19, 2020

March 17, 2:00 p.m. ET – Mark Yen, M.D., Arrowhead’s director of clinical development, will deliver an oral presentation titled, "Arrowhead TRiM Platform in the Clinic"

Oppenheimer 30th Annual Healthcare Conference – New York, March 17-18, 2020

March 18, 3:55 p.m. ET – Bruce Given will participate in a fireside chat presentation

A copy of the presentation materials and webcast links, if the presentation is being webcast, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.